- Home
- CR vs PEN Comparison
CR vs PEN Comparison
Compare CR & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CR
- PEN
- Stock Information
- Founded
- CR 1855
- PEN 2004
- Country
- CR United States
- PEN United States
- Employees
- CR N/A
- PEN N/A
- Industry
- CR Metal Fabrications
- PEN Medical/Dental Instruments
- Sector
- CR Industrials
- PEN Health Care
- Exchange
- CR Nasdaq
- PEN Nasdaq
- Market Cap
- CR 10.9B
- PEN 10.9B
- IPO Year
- CR N/A
- PEN 2015
- Fundamental
- Price
- CR $179.71
- PEN $278.56
- Analyst Decision
- CR Strong Buy
- PEN Strong Buy
- Analyst Count
- CR 5
- PEN 16
- Target Price
- CR $223.60
- PEN $307.19
- AVG Volume (30 Days)
- CR 289.8K
- PEN 485.7K
- Earning Date
- CR 10-27-2025
- PEN 11-05-2025
- Dividend Yield
- CR 0.51%
- PEN N/A
- EPS Growth
- CR 37.96
- PEN 367.34
- EPS
- CR 6.25
- PEN 4.14
- Revenue
- CR $2,268,100,000.00
- PEN $1,333,798,000.00
- Revenue This Year
- CR $10.97
- PEN $15.52
- Revenue Next Year
- CR $12.81
- PEN $14.20
- P/E Ratio
- CR $32.70
- PEN $67.20
- Revenue Growth
- CR 19.64
- PEN 14.61
- 52 Week Low
- CR $127.04
- PEN $221.26
- 52 Week High
- CR $203.89
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- CR 38.86
- PEN 65.28
- Support Level
- CR $175.63
- PEN $274.20
- Resistance Level
- CR $191.85
- PEN $284.91
- Average True Range (ATR)
- CR 5.51
- PEN 8.02
- MACD
- CR -1.47
- PEN 4.13
- Stochastic Oscillator
- CR 18.20
- PEN 91.01
About CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.